ARTICLE SUMMARY:
Orthopedics and other device companies are exploring the newly invigorated remote patient monitoring opportunity as a way to adapt to increasingly rigid CMS reimbursement. This gives them an important role in the fast-moving world of healthcare big data, but leaves other key components of that world like aggregation, analytics, and systemic perspectives up for grabs. A Q&A with Health Advances’ Paula Ness Speers and Greg Chittim.
Digital health and consumerism, backed by positive regulatory and reimbursement changes, are having a notable impact on medical device company strategies, and the interrelated rise of systemic telehealth.
